Sign In
Buy QTTB
$11.88
-0.770 (-6.09%)
At Close: Jun 23, 2026
Q32 Bio: "Buy" On Bempikibart Advancement And Mid-2026 Data Catalysts
09:18am, Thursday, 28'th May 2026
I initiate Q32 Bio (QTTB) at 'Buy' due to advancing bempikibart for Alopecia Areata and strong upcoming catalysts. Company expects mid-2026 data from both Part B [36-week topline] and Part A OLE of it
Q32 Bio Announces $55 Million Private Placement Financing
08:00am, Wednesday, 27'th May 2026
WALTHAM, Mass., May 27, 2026 /PRNewswire/ -- Q32 Bio Inc. (NASDAQ: QTTB) ("Q32 Bio" or "Company"), a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata
Wall Street Analysts Think Q32 Bio (QTTB) Could Surge 145.69%: Read This Before Placing a Bet
10:56am, Tuesday, 26'th May 2026
The average of price targets set by Wall Street analysts indicates a potential upside of 145.7% in Q32 Bio (QTTB). While the effectiveness of this highly sought-after metric is questionable, the posit
Wall Street Analysts Believe Q32 Bio (QTTB) Could Rally 163.42%: Here's is How to Trade
10:56am, Friday, 08'th May 2026
The consensus price target hints at a 163.4% upside potential for Q32 Bio (QTTB). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate
Q32 Bio Reports First Quarter 2026 Financial Results and Provides Corporate Update
06:59am, Tuesday, 05'th May 2026
-- Bempikibart 36-week topline data readout from Part B of SIGNAL-AA Phase 2a clinical trial on-track for mid-2026 -- -- First patient dosed in SIGNAL-AA Part B open-label extension (OLE) -- -- Comple
Q32 Bio to Participate in the 25th Annual Needham Virtual Healthcare Conference
06:59am, Wednesday, 08'th Apr 2026
WALTHAM, Mass., April 8, 2026 /PRNewswire/ -- Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata (AA) and ot
Does Q32 Bio (QTTB) Have the Potential to Rally 97.66% as Wall Street Analysts Expect?
10:55am, Monday, 30'th Mar 2026
The consensus price target hints at a 97.7% upside potential for Q32 Bio (QTTB). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate
Q32 Bio: Bempikibart Keeps The Alopecia Areata Bull Case Alive
08:33am, Monday, 30'th Mar 2026
Q32 Bio is now largely a single-asset story centered on Bempikibart in alopecia areata, with mid-2026 topline data as the key catalyst. Management sold ADX-097 to Akebia, which brings milestone and ro
Best Momentum Stocks to Buy for March 27th
11:16am, Friday, 27'th Mar 2026
MGY, ESCA, and QTTB made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on March 27, 2026.
New Strong Buy Stocks for March 27th
05:35am, Friday, 27'th Mar 2026
DNN, CM, MGY, QTTB and FLXS have been added to the Zacks Rank #1 (Strong Buy) List on March 27, 2026.
Q32 Bio (QTTB) Upgraded to Strong Buy: Here's What You Should Know
01:01pm, Thursday, 19'th Mar 2026
Q32 Bio (QTTB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Best Momentum Stocks to Buy for March 19th
11:15am, Thursday, 19'th Mar 2026
FIGS, QTTB and NESR made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on March 19, 2026.
New Strong Buy Stocks for March 19th
07:35am, Thursday, 19'th Mar 2026
FIGS, QTTB, ORN, FIX and PIPR have been added to the Zacks Rank #1 (Strong Buy) List on March 19, 2026.
Best Momentum Stocks to Buy for March 13th
11:01am, Friday, 13'th Mar 2026
QTTB, DXPE and TTEC made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on March 13th, 2026.
Wall Street Analysts See a 103.55% Upside in Q32 Bio (QTTB): Can the Stock Really Move This High?
10:55am, Friday, 13'th Mar 2026
The mean of analysts' price targets for Q32 Bio (QTTB) points to a 103.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analyst
